It was reported that variants of the angiotensin-converting enzyme 2 (ACE2) gene encode the cellular receptor for SARS-CoV-2, and polymorphisms of serine protease TMPRSS2 affect viral entry and invasion, thereby increasing COVID-19 severity [5, 6]. Here, ACE2 is linked to COVID-19.